Personal Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $539K | Sell |
7,954
-549
| -6% | -$37.2K | ﹤0.01% | 291 |
|
|
2022
Q3 | $466K | Buy |
8,503
+991
| +13% | +$54.3K | ﹤0.01% | 293 |
|
|
2022
Q2 | $496K | Buy |
7,512
+10
| +0.1% | +$660 | ﹤0.01% | 276 |
|
|
2022
Q1 | $498K | Sell |
7,502
-1,326
| -15% | -$88K | ﹤0.01% | 307 |
|
|
2021
Q4 | $500K | Buy |
8,828
+1,141
| +15% | +$64.6K | ﹤0.01% | 334 |
|
|
2021
Q3 | $462K | Sell |
7,687
-293
| -4% | -$17.6K | ﹤0.01% | 322 |
|
|
2021
Q2 | $478K | Sell |
7,980
-1,407
| -15% | -$84.3K | ﹤0.01% | 315 |
|
|
2021
Q1 | $467K | Sell |
9,387
-1,762
| -16% | -$87.7K | ﹤0.01% | 316 |
|
|
2020
Q4 | $557K | Buy |
11,149
+242
| +2% | +$12.1K | ﹤0.01% | 288 |
|
|
2020
Q3 | $598K | Buy |
10,907
+260
| +2% | +$14.3K | ﹤0.01% | 269 |
|
|
2020
Q2 | $563K | Sell |
10,647
-1,196
| -10% | -$63.2K | ﹤0.01% | 246 |
|
|
2020
Q1 | $529K | Buy |
11,843
+3,206
| +37% | +$143K | 0.01% | 252 |
|
|
2019
Q4 | $431K | Buy |
8,637
+1,997
| +30% | +$99.7K | ﹤0.01% | 279 |
|
|
2019
Q3 | $295K | Buy |
+6,640
| New | +$295K | ﹤0.01% | 295 |
|